To amend title XXVII of the Public Health Service Act to ensure the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program, and for other purposes.
Summary
What This Bill Does
The bill requires findings and purpose Congress finds the following: The 340B drug pricing program is an essential part of the Nation’s health care safety net, creates ensuring the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C, and creates requirements relating to the 340B drug discount program A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate. It relies on reporting requirements, compliance mandates, definition changes, and grants. The main policy areas are Agriculture, Healthcare, and Foreign Policy.
Who Benefits and How
Patients and health care consumers affected by the bill could face lower compliance burdens and Public beneficiaries or protected communities affected by the clause could face reduced risk.
Who Bears the Burden and How
Federal, state, or local agencies responsible for implementing the clause would take on compliance duties, Patients and health care consumers affected by the bill would take on compliance duties, and Foreign businesses and cross-border trade participants affected by the bill would take on compliance duties.
Key Provisions
- Requires findings and purpose Congress finds the following: The 340B drug pricing program is an essential part of the Nation’s health care safety net.
- Creates ensuring the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C.
- Creates requirements relating to the 340B drug discount program A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
The bill requires findings and purpose Congress finds the following: The 340B drug pricing program is an essential part of the Nation’s health care safety net, creates ensuring the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C, and creates requirements relating to the 340B drug discount program A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate.
Key Policy Areas
Agriculture, Healthcare, Foreign Policy
Primary Purpose
The bill requires findings and purpose Congress finds the following: The 340B drug pricing program is an essential part of the Nation’s health care safety net, creates ensuring the equitable treatment of covered entities and pharmacies participating in the 340B drug discount program Subpart II of part A of title XXVII of the Public Health Service Act (42 U.S.C, and creates requirements relating to the 340B drug discount program A group health plan, a health insurance issuer offering group or individual health insurance coverage, or a pharmacy benefit manager may not discriminate.
Policy Domains
Whole bill
Identified Gains
- Patients and health care consumers affected by the bill
- Public beneficiaries or protected communities affected by the clause
Identified Costs
- Federal, state, or local agencies responsible for implementing the clause
- Patients and health care consumers affected by the bill
- Foreign businesses and cross-border trade participants affected by the bill
- Agricultural producers and rural communities affected by the bill
- Public beneficiaries or protected communities affected by the clause
Sponsors
Legislative Progress
IntroducedMs. Spanberger (for herself and Mr. Johnson of South Dakota) …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology